Leveraging RWE to Widen Access to Therapies and Disrupt Treatment Pathways
How RWE can disrupt treatment pathways and unlock new commercial opportunities
While real-world evidence (RWE) has come to play a critical role in the pre- and post-approval drug process, it can deliver even greater value. RWE has the potential to influence HTA and payers, enabling long-term access and the reassessment of drugs to ensure treatment availability to expanded patient populations. But how can RWE demonstrate treatment effectiveness of new and existing drugs? What RWE will influence stakeholders? In this report experts explore the strategies, challenges and commercial benefits of RWE studies.
- Subject synopsis
- Research methodology and objectives
- Key insights summary
- Issues and insights
- Pharma’s use of RWE
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Sources of RWE
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Role of RWE in influencing treatment access
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Role of RWE in drug licensing
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Challenges to using RWE for disrupting the treatment pathway
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Early engagement with stakeholders to influence access
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Industry adaptation to incorporation of RWE
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Advice to pharma and opportunities
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook